South San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Spiral Therapeutics is raising $8,245,175.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Hugo Peris played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Spiral Therapeutics
We are a late pre-clinical stage company developing first-in-class therapies targeting inner ear disorders.

To learn more about Spiral Therapeutics, visit http://www.spiraltx.com/

Contact:
Hugo Peris, President and Chief Executive Officer
650-453-0893
https://www.linkedin.com/in/hugoperis/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved